LYCOS RETRIEVER
Rohypnol
built 631 days ago
Rohypnol is the trade name of a drug called Flunitrazepam. It is a kind of drug which contains powerful sedative, hypnotic, anxiolytic, anticonvulsant, amnestic and muscle-relaxant properties. The drug was first synthesized in the year 1970. Roche Holding AG, a company that is known for their contribution in Pharmaceutical industry was the first to manufacture Flunitrazepam (Rohypnol). In 1975, the drug became available in many places in Europe. The drug was used in hospitals for patients who needed deep sedation.
Source:
Rohypnol is being called the Date Rape Drug or the Quaalude of the '90s because it is the newest drug to be abused by adding it to alcohol. When combined with alcohol, marijuana, cocaine or other drugs, it can provide a rapid and dramatic high. Even if used by itself, Rohypnol's effects are very similar to intoxication. The drug usually sells for well below $5 per tablet.
Source:
Rohypnol has the potency to depress central nervous system activity and brain function. Pharmaceuticals, Specialty: 1Q05 Earnings Preview; Another Tough Quarter Barr Pharmaceuticals: Plan B Over-the-Counter a Step Closer? Barr Pharmaceuticals: Niaspan Settlement with Kos Boosts Long-Term Growth Rate Barr Pharmaceuticals: Low-Quality Quarter; No Change in Positive LT Stance on Stock Barr Pharmaceuticals: Low-Quality Qtr. and Slightly Lower EPS Guidance Pharmaceuticals, Specialty: Authorized Generics Are Probably Here to Stay Pharmaceuticals, Specialty: FTC Considering Study on Effect of Authorized Generics Pharmaceuticals, Specialty: 1Q05 Earnings Preview; Another Tough Quarter Barrier Therapeutics: Getting Closer to Commercializing the Pipeline Barrier Therapeutics: Zimycan Non-Approvable Is Disappointing Minor Setback Barrier Therapeutics: Trying to Keep the Faith in the Face of Disappointment Pharmaceuticals, Specialty: 1Q05 Earnings Preview; Another Tough Quarter Bausch & Lomb Inc.: Retisert Approval Good News For BOL U.S. Portfolio Strategy: Setting the Table for 2006 Bausch & Lomb Inc.: Another Good Qtr For BOL; EPS Guidance Raised ##TEXT##.05 Bausch & Lomb Inc.: Another Good Quarter; Numbers Still Going Up US Portfolio Strategy: Keeping It In Perspective STEP Portfolio Review: 1Q05 US Model Portfolio Review Hosp. Supplies & Medical Technology: 2Q05 Statistical Handbook: Trying to Maintain Some Balance Hosp. Supplies & Medical Technology: 2Q05 Statistical Handbook: Trying to Maintain Some Balance U.S. Portfolio Strategy: Setting the Table for 2006 Baxter International: Q1 First Look: Very Clean U.S. Portfolio Strategy: Coast to Coast Baxter International: Q1: Results of Restructuring in Sight.
Source:
Rohypnol has a synergistic effect with alcohol. When taken with alcohol, Rophypnol can cause severe disorientation and a loss of memory. These memory blackouts are typically 8-12 hours long. The victim may or may not appear "awake" during this time.
Source:
Illicit use of Rohypnol began in the 1970s in Europe and appeared in the United States in the early 1990s. Much of the concern surrounding Rohypnol is its abuse as a "date rape" drug. Rohypnol is a tasteless and odorless drug and, until recent manufacturer efforts, dissolved clear in liquid, which masked its presence. Rohypnol comes in pill form and is usually sold in the manufacturer’s bubble packaging, which can mislead users in the United States into believing the drug is safe and legal. Since February 1999, reformulated Rohypnol tablets, which turn blue in a drink to increase visibility, have been approved and marketed in 20 countries. The old non-colored tablets are still available....
Source:
The use of Rohypnol itself is dangerous, leading to physical and psychological dependence, which increases with dose and duration of use. However, there are other dangers linked to the use of this substance. Rohypnol is typically sold in its original bubble packaging, conveying a sense of legality and security in its use. The perceived safety of the drug along with the trend of use in combination with other substances, creates the possibility of Rohypnol becoming a gateway to harder drugs. An equally serious danger is the reported use of Rohypnol as a "date rape" drug of choice. While this specific use may not be pervasive, it is cause for concern.
Source: